Healthcare >> Analyst Interviews >> October 17, 2003
Investing In Biotechnology: David Wood – Rodman & Renshaw Inc
DAVID E. WOOD is a Senior Biotechnology Analyst at Rodman & Renshaw.
Prior to joining Rodman, Dr. Wood was an analyst in Stephens Inc's.
equity research department. He earned his PhD in molecular oncology and
immunology studying the molecular mechanism of chemotherapy-induced
apoptosis of leukemia cells. In addition, Dr. Wood carried out
postdoctoral training at Children's Hospital/Harvard Medical School
studying gene expression in Alzheimer's disease. He earned his PhD from
New York University School of Medicine and his BA in Biology from
Bowdoin College. Profile
TWST: Would you begin with an overview of your coverage?
Mr. Wood: I joined Rodman & Renshaw about three months ago and have been
developing a coverage list that will focus on companies